Therapeutics , Targets , and Chemical Biology A Systems Biology Approach Identi fi es Effective Tumor – Stroma Common Targets for Oral Squamous Cell Carcinoma
暂无分享,去创建一个
Y. Liu | Yun Wu | Hongmei Zhou | Lin Ge | Yurong Liu | Xiang-li Kong | Qinghong Gao | Xiaoyu Li | W. Meng | Sixiu Chen | Lan-yan Wu | Xin He | Chuanxia Liu | Q. Gao | Zhi Liang | Yiqing Guo
[1] C. Augustine,et al. Type III TGF-β receptor downregulation generates an immunotolerant tumor microenvironment. , 2013, The Journal of clinical investigation.
[2] Sebastian Munck,et al. Loss of PPP2R2A inhibits homologous recombination DNA repair and predicts tumor sensitivity to PARP inhibition. , 2012, Cancer research.
[3] Amin R. Mazloom,et al. Activation of Alternate Prosurvival Pathways Accounts for Acquired Sunitinib Resistance in U87MG Glioma Xenografts , 2012, Journal of Pharmacology and Experimental Therapeutics.
[4] B. Al-Lazikani,et al. Combinatorial drug therapy for cancer in the post-genomic era , 2012, Nature Biotechnology.
[5] F. Markowetz,et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups , 2012, Nature.
[6] Mina J Bissell,et al. The tumor microenvironment is a dominant force in multidrug resistance. , 2012, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[7] William C Hines,et al. Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression , 2011, Nature Medicine.
[8] Hongmei Zhou,et al. Downregulation of TGF-beta receptor types II and III in oral squamous cell carcinoma and oral carcinoma-associated fibroblasts , 2011, BMC Cancer.
[9] T. Udagawa,et al. Tumor-stromal cell interactions and opportunities for therapeutic intervention. , 2010, Current opinion in pharmacology.
[10] Gerard C Blobe,et al. Roles for the type III TGF-beta receptor in human cancer. , 2010, Cellular signalling.
[11] C. Sander,et al. Integrative genomic profiling of human prostate cancer. , 2010, Cancer cell.
[12] A. Howell,et al. Breast tumour stroma is a prognostic indicator and target for therapy , 2009, Breast Cancer Research.
[13] N. Ferrara,et al. Tumor and stromal pathways mediating refractoriness/resistance to anti-angiogenic therapies. , 2009, Trends in pharmacological sciences.
[14] G. Blobe,et al. The type III TGF-β receptor regulates epithelial and cancer cell migration through β-arrestin2-mediated activation of Cdc42 , 2009, Proceedings of the National Academy of Sciences.
[15] A. Ostman,et al. Cancer-associated fibroblasts and tumor growth--bystanders turning into key players. , 2009, Current opinion in genetics & development.
[16] M. Daly,et al. Genetic Mapping in Human Disease , 2008, Science.
[17] Y. Okamoto,et al. Identification of a novel therapeutic target for head and neck squamous cell carcinomas: A role for the neurotensin‐neurotensin receptor 1 oncogenic signaling pathway , 2008, International journal of cancer.
[18] Pengyuan Liu,et al. Common Human Cancer Genes Discovered by Integrated Gene-Expression Analysis , 2007, PloS one.
[19] K. Gunsalus,et al. Network modeling links breast cancer susceptibility and centrosome dysfunction. , 2007, Nature genetics.
[20] T. Ideker,et al. Network-based classification of breast cancer metastasis , 2007, Molecular systems biology.
[21] Brad T. Sherman,et al. The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists , 2007, Genome Biology.
[22] E. Wang,et al. Genetic studies of diseases , 2007, Cellular and Molecular Life Sciences.
[23] G. Blobe,et al. The type III transforming growth factor-beta receptor as a novel tumor suppressor gene in prostate cancer. , 2007, Cancer research.
[24] Raghu Kalluri,et al. Fibroblasts in cancer , 2006, Nature Reviews Cancer.
[25] J. Joyce,et al. Therapeutic Targeting of the Tumor Microenvironment. , 2021, Cancer discovery.
[26] N. Fusenig,et al. Friends or foes — bipolar effects of the tumour stroma in cancer , 2004, Nature Reviews Cancer.
[27] Patricia Soteropoulos,et al. Association between gene expression profile and tumor invasion in oral squamous cell carcinoma. , 2004, Cancer genetics and cytogenetics.
[28] Massimo Marchiori,et al. Error and attacktolerance of complex network s , 2004 .
[29] Arun K. Ramani,et al. Protein interaction networks from yeast to human. , 2004, Current opinion in structural biology.
[30] Stuart M. Brown,et al. Selection and validation of differentially expressed genes in head and neck cancer , 2004, Cellular and Molecular Life Sciences CMLS.
[31] H. Kitano. Cancer as a robust system: implications for anticancer therapy , 2004, Nature Reviews Cancer.
[32] T. Hubbard,et al. A census of human cancer genes , 2004, Nature Reviews Cancer.
[33] A. Barabasi,et al. Network biology: understanding the cell's functional organization , 2004, Nature Reviews Genetics.
[34] P. Shannon,et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.
[35] L. Mirny,et al. Protein complexes and functional modules in molecular networks , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[36] Richard Wooster,et al. Sequence-based cancer genomics: progress, lessons and opportunities , 2003, Nature Reviews Genetics.
[37] A. Barabasi,et al. Error and attack tolerance of complex networks , 2000, Nature.
[38] J. Hopfield,et al. From molecular to modular cell biology , 1999, Nature.
[39] A. Azmi. Systems Biology in Cancer Research and Drug Discovery , 2012, Springer Netherlands.
[40] P. Cirri,et al. Cancer associated fibroblasts: the dark side of the coin. , 2011, American journal of cancer research.
[41] R. Bagley. Comprar The Tumor Microenvironment | Bagley, Rebecca G. | 9781441966148 | Springer , 2010 .
[42] C. Sawyers,et al. Targeted cancer therapy , 2004, Nature.